Membranous Nephropathy - 7 Studies Found
| Active, not recruiting |
: Acthar for Treatment of Proteinuria in Membranous Nephropathy Patients :
: 2011-06-29 :
|
| Completed |
: Tacrolimus Combined With Prednisone Treatment of Idiopathic Membranous Nephropathy and Nephrotic Syndrome :
: 2006-08-09 : Drug: tacrolimus combined with prednisone |
| Completed |
: Analysis of T- and B-Cell Subpopulations in Membranous Nephropathy : : 2025-07-30 |
| NOT_YET_RECRUITING |
: REmission in Membranous Nephropathy International Trial (REMIT) : Primary Membranous Nephropathy : 2025-07-30 : Participants will receive an intravenous infusion of 1,000mg Obinutuzumab at Weeks 0, 2, 24 and 26.Prior to the administration of obinutuzum |
| Completed |
: A Study to Evaluate the Safety and Efficacy of Zanubrutinib in Participants With Primary Membranous Nephropathy : Primary Membranous Nephropathy : 2025-07-30 : Participants will receive zanubrutinib once daily |
| Completed |
: A Study of SNP-ACTH (1-39) Gel in Patients With Primary Membranous Nephropathy : Primary Membranous Nephropathy : 2025-07-30 : Subjects will be randomly assigned in 1:1 treatment allocation ratio to receive the test and reference product. |
| COMPLETED |
: MOR202 for Refractory MN : Membranous Nephropathy : 2025-07-30 : Each patient will be treated for 24 weeks and received a total of 9 doses.During the first treatment cycle, MOR202 will be administered weekly. |